An Ambulnz vehicle in New York. Photo: Courtesy of Nicole Zhu via Twitter

Ambulnz, a startup that dispatches non-emergency ambulances, has filed paperwork with the Securities and Exchange Commission to raise $90 million in outside funding. The company did not respond to multiple attempts for comment.

The bottom line: Ambulnz is seeking a lot of cash, but it's unclear how the company operates.

What they're not saying: The Ambulnz website is sparse on details, and there's no explanation of how it earns money or how it works with health insurers.

  • Several company phone extensions led to busy signals or voicemails. Calls to Ambulnz CFO Andre Oberholzer were not returned. LinkedIn messages to Oberholzer and CEO Stan Vashovsky were not returned. Emails to support@ambulnz.com, which is referenced on the company's terms of service and privacy policy, generated bounceback messages.

What we know: Ambulnz says it offers "non-emergency patient transportation services," such as moving patients between hospitals and nursing homes or getting people to their doctor appointments. Uber and Lyft do this as well.

  • That means Ambulnz isn't providing rides for people who get shot, have heart attacks or encounter other emergencies. Those still require a 911 call.
  • One EMT for Ambulnz explained in a video the company pays based on how many rides they complete — "the more calls you run, the more money you make."

The services are expensive.

  • An Ambulnz representative said its standard rides were $350 plus $10 per mile. If a nurse is needed on board, it goes to $850 plus the mileage. The representative said the company "expects payment upfront," but rates could depend on insurance.
  • Ambulnz's rates are well above the $225 Medicare pays for basic non-emergency ambulance transports. And even higher above what an Uber or Lyft ride would likely cost (remember: this isn't for emergencies).
  • The company's fees are tied to a "local market rate card" and "available upon request." Axios has requested them, but has not received a copy yet.

The big picture: Like other premium health care services, we don't know how big the market and demand for this particular service is, given the high cost, narrow purpose and cheaper alternatives.

Go deeper

Senate to vote on Amy Coney Barrett's confirmation on Oct. 26

Senate Majority Leader Mitch McConnell (R-KY) in the Capitol on Oct. 20. Photo: Stefani Reynolds/Getty Images

The Senate will vote to confirm Judge Amy Coney Barrett to the Supreme Court next Monday, Oct. 26, Majority Leader Mitch McConnell (R-Ky.) announced Tuesday.

The big picture: The Senate Judiciary Committee will vote this Thursday to advance Barrett's nomination to the full Senate floor. Democrats have acknowledged that there's nothing procedurally that they can do to stop Barrett's confirmation, which will take place just one week out from Election Day.

Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Politics: Americans feel Trump's sickness makes him harder to trustFlorida breaks record for in-person early voting.
  2. Health: The next wave is gaining steam.
  3. Education: Schools haven't become hotspots.
  4. World: Ireland moving back into lockdown — Argentina becomes 5th country to report 1 million infections.

Meadows confirms Trump's tweets "declassifying" Russia documents were false

Photo: Tom Williams-Pool/Getty Images

White House Chief of Staff Mark Meadows confirmed in court on Tuesday that President Trump's tweets authorizing the disclosure of documents related to the Russia investigation and Hillary Clinton's emails "were not self-executing declassification orders," after a federal judge demanded that Trump be asked about his intentions.

Why it matters: BuzzFeed News reporter Jason Leopold cited the tweets in an emergency motion seeking to gain access to special counsel Robert Mueller's unredacted report as part of a Freedom of Information Act request. This is the first time Trump himself has indicated, according to Meadows, that his tweets are not official directives.